Older patients with bladder cancer had a higher risk of cardiovascular-related death compared to the general older adult population (SMR 1.30; 95% CI 1.28-1.32).
Cohort (n=80,042)
What is the risk of cardiovascular death in older patients with bladder cancer compared to the general older adult population?
Older patients with bladder cancer have a significantly higher risk of cardiovascular death compared to the general population, with CVD becoming the leading cause of death 5-10 years post-diagnosis.
Effect estimate: SMR 1.30 (95% CI 1.28-1.32)
BACKGROUND: To identify the risk of death from cardiovascular disease (CVD) in older patients with bladder cancer (BC). METHODS: This population-based study included 80,042 older BC patients (≥65 years) diagnosed between 1975 and 2018, with a mean follow-up of 17.2 years. The proportion of deaths, competing risk models, standardized mortality ratio (SMR), and absolute excess risk (AER) per 10,000 person-years were applied to identify the risk of CVD-related deaths among older BC patients. RESULTS: For older patients with BC, CVD-related death was the chief cause of death, and cumulative CVD-related mortality also exceeded primary BC as the leading cause of death mostly 5-10 years after BC diagnosis, especially in localized-stage and low-grade subgroups. The risk of short- and long-term CVD-related death in older BC patients was higher than in the general older adult population (SMR = 1.30, 95% CI 1.28-1.32; AER = 105.68). The risk of sex-specific CVD-related deaths also increased compared to the general population of older adults, including heart disease, cerebrovascular diseases, hypertension without heart disease, atherosclerosis, aortic aneurysm and dissection, and other diseases of the arteries, arterioles, and capillaries. CONCLUSIONS: CVD-related death is an important competing risk among older BC patients and has surpassed primary BC as the chief cause of death, mainly 5-10 years after BC diagnosis. The risk of CVD-related death in older patients with BC was greater than in the general population. The management of older patients with BC should focus not only on the primary cancer but also on CVD-related death.
Guan et al. (Wed,) conducted a cohort in Bladder cancer (n=80,042). Bladder cancer vs. General older adult population was evaluated on Risk of CVD-related death (SMR 1.30, 95% CI 1.28-1.32). Older patients with bladder cancer had a higher risk of cardiovascular-related death compared to the general older adult population (SMR 1.30; 95% CI 1.28-1.32).